All NHS guideline articles
View all stories of the same content type.
-
NHS guidelinePHE maintaining immunisation programmes during COVID-19
A brief summary providing the key points for primary care on maintaining immunisation programmes during the COVID-19 pandemic
-
NHS guideline
NHS hepatitis C antibody testing guidance for community pharmacy
Summarised information on offering HCV antibody testing in community pharmacy
-
NHS guideline
OTC quick reference guide
A quick reference tool summarising CCG guidance on conditions for which over-the-counter items should not routinely be prescribed in primary care.
-
NHS guideline
NHS England COVID-19 guidance for community pharmacy
This standard operating procedure summary sets out general principles for the delivery of services during the COVID-19 pandemic, and requires local interpretation
-
NHS guideline
Pharmacy Quality Scheme (PQS) 2020/2021 part 2
This summary of the Pharmacy Quality Scheme (PQS) 2020/21 is intended as an aide-memoir or checklist for community pharmacists and must be viewed in conjuction with the full guidance which gives detailed instructions on what must be completed and submitted
-
NHS guideline
Pharmacy Quality Scheme (PQS) 2020/2021 part 1
Overview This summary of the Pharmacy Quality Scheme (PQS) 2020/21 is intended as an aide-memoir or checklist for community pharmacists and must be viewed in conjuction with the full guidance which gives detailed instructions on what must be completed and submitted. View the Pharmacy ...
-
NHS guideline
NHS guideline for delivering diabetes care during COVID-19
This NHS guidance for general practice covers the key points of delivering diabetes care during the challenging times of the COVID-19 pandemic
-
NHS guideline
NHS video consulting guideline
This Guidelines summary covers guidance for safe video consulting in general practice during the COVID-19 pandemic
-
NHS guideline
NHS guidance on NSAIDs in COVID-19
This summary sets out the clinical policy for the acute use of non-steroidal anti-inflammatory drugs (NSAIDs) in people with or at risk of COVID-19.
